Professor, University of British Columbia and Vancouver Prostate Centre, Canada

Dr. Collins career began at San Francisco State University where he obtained a Certificate in genetic engineering in 1985. He then worked at Lawrence Livermore National Laboratory where he participated in the earliest stages of the Human Genome Program and the pioneering of molecular cytogenetics. Dr. Collins obtained a PhD in Medical Genetics in 1993 from the University of British Columbia after which he became faculty at Lawrence Berkeley National Laboratory (LBNL). At LBNL Dr. Collins was a cofounder of the Resource for Molecular Cytogenetics in the Department of Life Sciences. In 1998 Dr. Collins moved to the University of California San Francisco’s (UCSF) Comprehensive Cancer Center. At UCSF Dr. Collins invented and patented “paired end sequencing”, the method by which almost all modern sequencing is done, and was the first to sequence a tumor genome. He also was the first to show that genome copy number aberrations can be used to risk stratify men with prostate cancer for metastasis. This work also received a patent. In 2009 Dr. Collins relocated to the University of British Columbia (UBC) and the Vancouver Prostate Centre (VPC). At the VPC Dr. Collins Directs the Laboratory for Advanced Genome Analysis (LAGA) and the Beijing Genome Institute (BGI)-VPC Joint Research Laboratory.  These support genome and computational biology research within the VPC, Canada, and internationally. It also supports a precision oncology program at the VPC. Dr. Collins has a keen interest in treatment resistant prostate cancer where he and his collaborators have made key discoveries into the mechanisms of therapeutic resistance, identification of novel therapeutic targets and the development of blood-based liquid biopsies for prostate and other cancers. He has had a lifelong interest in space exploration and astronomy and serves as an adviser to the Exomedicine Institute. Dr. Collins has appointments at Simon Fraser University in the School of Computing Science and at BGI in the Think Tank Division. He has over 190 publications and multiple patents.